Company page

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. (ticker: CGTX) is a public company based in the United States, focusing on developing innovative therapies for neurodegenerative diseases. With a market capitalization of approximately $115.45 million, the company is dedicated to advancing its research and development efforts in the healthcare sector.